Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial
Published Online: 2023-01-?
Journal: The Lancet Infectious Diseases•Publisher: Elsevier BV
Authors: Alexander Alexandrov•Anita Pathil•Antje Blank•Birgit Bremer•Florian A Lempp•Heiner Wedemeyer•Igor G Bakulin•Ilsiyar Khaertynova•Julian Schulze zur Wiesch•Katrin Schöneweis•Kerstin Port•Lena Allweiss•Marina Osipenko•Marina Rusanova•Markus Cornberg•Mathias Haag•Matthias Schwab•Maura Dandri•Natalia Geyvandova•Natalia Voronkova•Olga Sagalova•Pavel Bogomolov•Snezhana Sleptsova•Stephan Urban•Tatiana Stepanova•Uta Merle•Viacheslav Morozov•Vladimir Chulanov•Walter E Haefeli
